Demant
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 c
Tags Tree
Selected: 0
No matching results found.
- Provide a detailed account of your organization's significant operational and capital expenditures necessary for the execution of your climate change mitigation transition plan, as outlined in Disclosure Requirement E1-1. This should include an explanation and quantification of investments and funding, referencing the key performance indicators of taxonomy-aligned capital expenditures, and, where applicable, the capital expenditure plans disclosed in accordance with Commission Delegated Regulation (EU) 2021/2178.
-
Question Id: E1-1_04
The financial resources required for the implementation of the decarbonisation levers and their relation to the financial statements are yet to be determined, as this depends on further defining the decarbonisation levers and their mitigation actions.
Report Date: 4Q2024Relevance: 30%
- Has the reporting undertaking experienced any significant changes in the definition of what constitutes its entity and its upstream and downstream value chain? If so, provide a detailed disclosure of these changes and explain their impact on the year-to-year comparability of the reported Gross Scopes 1, 2, 3, and Total GHG emissions, specifically addressing the comparability between the current and previous reporting periods.
-
Question Id: E1-6_14
In 2024, the company changed its Scope 3 accounting policy by applying a new, more accurate method. The comparative and baseline figures have been adjusted accordingly. For 2024, the total effect of the change in accounting policy is estimated to be approximately 250,000 tonnes lower CO2e compared to the previous method.
Report Date: 4Q2024Relevance: 50%